Clincosm LogoSign in Get a demo

primary biliary cholangitis

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Biliary Cholangitis Trial in Suzhou ([14C]CS0159)

Not yet recruiting
  • Primary Biliary Cholangitis
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Oct 18, 2023

Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Seladelpar 10 mg
  • Placebo
  • Chandler, Arizona
  • +3 more
Oct 2, 2023

Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Seladelpar 10 mg
  • Placebo
  • Lancaster, California
  • +4 more
Sep 26, 2023

Program for Primary Biliary Cholangitis Lost in the System

Recruiting
  • Primary Biliary Cholangitis
    • Terrassa, Barcelona, Spain
      Hospital Universitari MútuaTerrassa
    Jun 16, 2023

    Primary Biliary Cholangitis, Heart Failure, Obesity Trial in Edmonton (Online mind-body wellness program, Online mind-body

    Recruiting
    • Primary Biliary Cholangitis
    • +9 more
    • Online mind-body wellness program
    • Online mind-body wellness program + Weekly Check-ins
    • Edmonton, Alberta, Canada
      University of Alberta
    Mar 27, 2023

    Primary Biliary Cholangitis Trial in Xi'an (Fenofibrate 200mg, Placebo, UDCA)

    Recruiting
    • Primary Biliary Cholangitis
    • Fenofibrate 200mg
    • +2 more
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Mar 3, 2023

    Primary Biliary Cholangitis Trial in Xi'an (Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With

    Recruiting
    • Primary Biliary Cholangitis
    • Placebo Combined With Ursodeoxycholic Acid
    • Fenofibrate Combined With Ursodeoxycholic Acid
    • Xi'an, Shaanxi, China
      Ying han
    Mar 3, 2023

    Primary Biliary Cholangitis Trial in Worldwide (Seladelpar 10 mg, Placebo, Seladelpar 5 mg)

    Active, not recruiting
    • Primary Biliary Cholangitis
    • Seladelpar 10 mg
    • +2 more
    • Chandler, Arizona
    • +128 more
    Jan 27, 2023

    Primary Biliary Cholangitis Trial in United States (CNP-104, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Coronado, California
    • +18 more
    Jan 19, 2023

    Primary Biliary Cholangitis Trial in Shanghai (CS0159, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Shanghai, China
      Shanghai Xuhui Central Hospital
    Dec 29, 2022

    Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

    Enrolling by invitation
    • Primary Biliary Cholangitis
    • Obeticholic Acid 5 MG
    • +2 more
    • San Diego, California
      Intercept Pharmaceuticals, Inc
    Dec 15, 2022

    Primary Biliary Cholangitis Trial in Worldwide (Obeticholic acid, Bezafibrate 200 MG, OCA Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Obeticholic acid
    • +5 more
    • Bedford Park, Perth, Australia
    • +67 more
    Dec 2, 2022

    Primary Biliary Cholangitis Trial in United States (Bezafibrate 100 MG, Bezafibrate 200 MG, Obeticholic Acid 5 MG)

    Recruiting
    • Primary Biliary Cholangitis
    • Bezafibrate 100 MG
    • +4 more
    • Dothan, Alabama
    • +25 more
    Aug 24, 2022

    Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

    Completed
    • Primary Biliary Cholangitis
    • Obeticholic Acid 5 MG
    • +2 more
    • San Diego, California
      Intercept Pharmaceuticals, Inc
    Jul 30, 2022

    Primary Biliary Cholangitis Trial in Beijing (Obeticholic Acid Tablets(OCA), UDCA, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Obeticholic Acid Tablets（OCA）
    • +2 more
    • Beijing, China
      Beijing Friendship Hospital
    Jul 7, 2022

    Primary Biliary Cholangitis, Primary Biliary Cirrhosis, Cholangitis Trial in United States (HTD1801 (BUDCA))

    Completed
    • Primary Biliary Cholangitis
    • +5 more
    • HTD1801 (BUDCA)
    • Miami, Florida
    • +11 more
    Jun 24, 2022

    Primary Biliary Cholangitis Trial in Beijing (ursodeoxycholic acid)

    Recruiting
    • Primary Biliary Cholangitis
    • ursodeoxycholic acid
    • Beijing, China
      Peking Union Medical College Hospital
    Apr 28, 2022

    Primary Biliary Cholangitis Trial in Indianapolis (Saroglitazar Magnesium 1 mg, Saroglitazar Magnesium 2 mg, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Saroglitazar Magnesium 1 mg
    • +2 more
    • Indianapolis, Indiana
      Zydus site 1
    Apr 28, 2022

    Primary Biliary Cholangitis Trial in Canada (Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Raltegravir, Placebo Oral Capsule

    Recruiting
    • Primary Biliary Cholangitis
    • Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)
    • +2 more
    • Edmonton, Alberta, Canada
    • +5 more
    Mar 15, 2022

    Primary Biliary Cholangitis Trial in Australia, New Zealand, United States (APD334)

    Terminated
    Has Results
    • Primary Biliary Cholangitis
    • Sacramento, California
    • +8 more
    Feb 28, 2022

    Primary Biliary Cholangitis Trial (ASC42 5 mg, ASC42 10 mg, ASC42 15 mg)

    Not yet recruiting
    • Primary Biliary Cholangitis
    • ASC42 5 mg
    • +3 more
    • (no location specified)
    Mar 9, 2022

    Primary Biliary Cholangitis Trial in Italy (Clinical information)

    Recruiting
    • Primary Biliary Cholangitis
    • Clinical information
    • Ancona, Italy
    • +42 more
    Nov 25, 2021

    Primary Biliary Cholangitis

    Recruiting
    • PBC
    • Primary Biliary Cholangitis
    • Aachen, Germany
    • +43 more
    Aug 6, 2021

    Hepatitis, Autoimmune, Primary Biliary Cholangitis, Immunosuppression Trial in Chengdu (Cyclosporin A, Mycophenolate Mofetil)

    Recruiting
    • Hepatitis, Autoimmune
    • +2 more
    • Cyclosporin A
    • Mycophenolate Mofetil
    • Chengdu, Sichuan, China
      WestChina Hospital
    Jun 16, 2021

    Primary Biliary Cholangitis Trial in Worldwide (EDP-305 1 mg, EDP-305 2.5 mg, Placebo)

    Completed
    Has Results
    • Primary Biliary Cholangitis
    • EDP-305 1 mg
    • +2 more
    • Dothan, Alabama
    • +85 more
    Apr 27, 2021